Nutex Health (NASDAQ:NUTX) Shares Down 5.9% – Here’s Why

Nutex Health Inc. (NASDAQ:NUTX)’s share price fell 5.9% on Tuesday . The stock traded as low as $115.00 and last traded at $110.75. 53,381 shares changed hands during mid-day trading, a decline of 28% from the average session volume of 74,106 shares. The stock had previously closed at $117.66.

Wall Street Analyst Weigh In

A number of research firms have weighed in on NUTX. Wall Street Zen cut shares of Nutex Health from a “strong-buy” rating to a “buy” rating in a research report on Thursday, May 22nd. Benchmark boosted their target price on Nutex Health from $150.00 to $300.00 and gave the stock a “buy” rating in a research note on Thursday, May 15th. Finally, Maxim Group lifted their price objective on Nutex Health from $100.00 to $225.00 and gave the company a “buy” rating in a report on Tuesday, May 20th.

Nutex Health Trading Down 2.9%

The company has a debt-to-equity ratio of 3.36, a quick ratio of 1.74 and a current ratio of 1.77. The business has a fifty day moving average price of $133.49 and a 200 day moving average price of $75.79. The company has a market capitalization of $634.44 million, a PE ratio of -12.20 and a beta of 0.04.

Nutex Health (NASDAQ:NUTX) last released its earnings results on Tuesday, May 13th. The company reported $2.56 EPS for the quarter, beating the consensus estimate of ($0.15) by $2.71. The firm had revenue of $211.79 million for the quarter, compared to analysts’ expectations of $81.09 million. Nutex Health had a negative net margin of 14.09% and a negative return on equity of 51.27%.

Insider Buying and Selling at Nutex Health

In other Nutex Health news, CFO Jon Christian Bates acquired 1,000 shares of Nutex Health stock in a transaction that occurred on Tuesday, April 8th. The stock was purchased at an average cost of $81.81 per share, with a total value of $81,810.00. Following the purchase, the chief financial officer now owns 4,888 shares in the company, valued at approximately $399,887.28. The trade was a 25.72% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Insiders own 38.52% of the company’s stock.

Institutional Inflows and Outflows

Several large investors have recently added to or reduced their stakes in NUTX. Topline Capital Management LLC acquired a new position in shares of Nutex Health in the fourth quarter worth $5,690,000. Essex Investment Management Co. LLC lifted its position in shares of Nutex Health by 45.4% in the fourth quarter. Essex Investment Management Co. LLC now owns 105,809 shares of the company’s stock worth $3,353,000 after buying an additional 33,024 shares during the last quarter. American Century Companies Inc. boosted its stake in shares of Nutex Health by 73.0% during the 1st quarter. American Century Companies Inc. now owns 74,359 shares of the company’s stock worth $3,497,000 after acquiring an additional 31,366 shares in the last quarter. Ancora Advisors LLC acquired a new position in shares of Nutex Health during the 4th quarter valued at about $1,334,000. Finally, Truist Financial Corp raised its stake in shares of Nutex Health by 22.2% in the 4th quarter. Truist Financial Corp now owns 35,570 shares of the company’s stock valued at $1,127,000 after acquiring an additional 6,454 shares in the last quarter. Institutional investors and hedge funds own 5.32% of the company’s stock.

About Nutex Health

Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.